Abstract
A single heat shock factor (HSF), mediating the heat shock response, exists from yeast to Drosophila, whereas several related HSFs have been found in mammals. This raises the question of the specific or redundant functions of the different members of the HSF family and in particular of HSF1 and HSF2, which are both ubiquitously expressed. Using immortalized mouse embryonic fibroblasts (iMEFs) derived from wild-type, Hsf1−/−, Hsf2−/− or double-mutant mice, we observed the distinctive behaviors of these mutants with respect to proteasome inhibition. This proteotoxic stress reduces to the same extent the viability of Hsf1−/−- and Hsf2−/−-deficient cells, but through different underlying mechanisms. Contrary to Hsf2−/− cells, Hsf1−/− cells are unable to induce pro-survival heat shock protein expression. Conversely, proteasome activity is lower in Hsf2−/− cells and the expression of some proteasome subunits, such as Psmb5 and gankyrin, is decreased. As gankyrin is an oncoprotein involved in p53 degradation, we analyzed the status of p53 in HSF-deficient iMEFs and observed that it was strongly stabilized in Hsf2−/− cells. This study points a new role for HSF2 in the regulation of protein degradation and suggests that pan-HSF inhibitors could be valuable tools to reduce chemoresistance to proteasome inhibition observed in cancer therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akerfelt M, Trouillet D, Mezger V, Sistonen L . (2007). Heat shock factors at a crossroad between stress and development. Ann N Y Acad Sci 1113: 15–27.
Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T et al. (2000). Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2: 469–475.
Beere HM . (2005). Death versus survival: functional interaction between the apoptotic and the stress-inducible heat shock protein pathways. J Clin Invest 115: 2633–2639.
Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C et al. (2000). Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2: 645–652.
Bush KT, Goldberg AL, Nigam SK . (1997). Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 272: 9086–9092.
Busse A, Kraus M, Na IK, Rietz A, Scheibenbogen C, Driessen C et al. (2008). Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits. Cancer 112: 659–670.
Cantalupo PG, Sáenz-Robles MT, Rathi AV, Beerman RW, Patterson WH, Whitehead RH et al. (2009). Cell-type specific regulation of gene expression by simian virus 40T antigens. Virology 386: 183–191.
Dai C, Whitesell L, Rogers AB, Lindquist S . (2007). Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130: 1005–1018.
Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG . (2000). Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol 18: 538–543.
Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C . (2008). Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem 103: 270–283.
Hahn JS, Neef DW, Thiele DJ . (2006). A stress regulatory network for co-ordinated activation of proteasome expression mediated by yeast heat shock transcription factor. Mol Microbiol 60: 240–251.
Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J . (2007). qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T et al. (2000). Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 6: 96–99.
Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Nagao T, Sumitomo H et al. (2005). The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 8: 75–87.
Homma S, Jin X, Wang G, Tu N, Min J, Yanasak N et al. (2007). Demyelination, astrogliosis and accumulation of ubiquitinated proteins, hallmarks of CNS disease in hsf1-deficient mice. J Neurosci 27: 7974–7986.
Jin X, Moskophidis D, Hu Y, Phillips A, Mivechi NF . (2009). Heat shock factor 1 deficiency via its downstream target gene alphaB-crystallin (Hspb5) impairs p53 degradation. J Cell Biochem 107: 504–515.
Kawazoe Y, Nakai A, Tanabe M, Nagata K . (1998). Proteasome inhibition leads to the activation of all members of the heat-shock-factor family. Eur J Biochem 255: 356–362.
Kisselev AF, Goldberg AL . (2005). Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol 398: 364–378.
Kroeger PE, Morimoto RI . (1994). Selection of new HSF1 and HSF2 DNA-binding sites reveals difference in trimer cooperativity. Mol Cell Biol 14: 7592–7603.
Loison F, Debure L, Nizard P, le Goff P, Michel D, le Dréan Y . (2006). Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. Biochem J 395: 223–231.
McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ . (1998). Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J Biol Chem 273: 7523–7528.
McMillan DR, Christians E, Forster M, Xiao X, Connell P, Plumier JC et al. (2002). Heat shock transcription factor 2 is not essential for embryonic development, fertility, or adult cognitive and psychomotor function in mice. Mol Cell Biol 22: 8005–8014.
Meiners S, Heyken D, Weller A, Ludwig A, Stangl K, Kloetzel PM et al. (2003). Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J Biol Chem 278: 21517–21525.
Muratani M, Tansey WP . (2003). How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4: 192–201.
Nencioni A, Grünebach F, Patrone F, Ballestrero A, Brossart P . (2007). Proteasome inhibitors: antitumor effects and beyond. Leukemia 21: 30–36.
Oerlemans R, Franke NE, Assaraf YG, Cloos J, van Zantwijk I, Berkers CR et al. (2008). Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood 112: 2489–2499.
Ostling P, Björk JK, Roos-Mattjus P, Mezger V, Sistonen L . (2007). Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1. J Biol Chem 282: 7077–7086.
Paul S . (2008). Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Bioessays 30: 1172–1184.
Pickart CM, Cohen RE . (2004). Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 5: 177–187.
Pipas JM, Levine AJ . (2001). Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 11: 23–30.
Pirkkala L, Alastalo TP, Zuo X, Benjamin IJ, Sistonen L . (2000). Disruption of heat shock factor 1 reveals an essential role in the ubiquitin proteolytic pathway. Mol Cell Biol 20: 2670–2675.
Pirkkala L, Nykänen P, Sistonen L . (2001). Roles of heat shock transcription factors in regulation of heat shock response and beyond. FASEB J 15: 1118–1131.
Rückrich T, Kraus M, Gogel J, Beck A, Ovaa H, Verdoes M et al. (2009). Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells. Leukemia 23: 1098–1105.
Sandqvist A, Björk JK, Akerfelt M, Chitikova Z, Grichine A, Vourc′h C et al. (2009). Heterotrimerization of heat-shock factors 1 and 2 provides a transcriptional switch in response to distinct stimuli. Mol Biol Cell 20: 1340–1347.
Sato Y, Sakamoto K, Sei M, Ewis AA, Nakahori Y . (2009). Proteasome subunits are regulated and expressed in comparable concentrations as a functional cluster. Biochem Biophys Res Commun 378: 795–798.
Schwartz AL, Ciechanover A . (1999). The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50: 57–74.
Sistonen L, Sarge KD, Phillips B, Abravaya K, Morimoto RI . (1992). Activation of heat shock factor 2 during hemin-induced differentiation of human erythroleukemia cells. Mol Cell Biol 12: 4104–4111.
Taylor DM, Kabashi E, Agar JN, Minotti S, Durham HD . (2005). Proteasome activity or expression is not altered by activation of the heat shock transcription factor Hsf1 in cultured fibroblasts or myoblasts. Cell Stress Chaperones 10: 230–241.
Trinklein ND, Murray JI, Hartman SJ, Botstein D, Myers RM . (2004). The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response. Mol Biol Cell 15: 1254–1261.
Tsirigotis M, Thurig S, Dubé M, Vanderhyden BC, Zhang M, Gray DA . (2001). Analysis of ubiquitination in vivo using a transgenic mouse model. Biotechniques 31: 120–130.
Twombly R . (2003). First proteasome inhibitor approved for multiple myeloma. J Natl Cancer Inst 95: 845.
Wilkerson DC, Skaggs HS, Sarge KD . (2007). HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression. Cell Stress Chaperones 12: 283–290.
Xing H, Wilkerson DC, Mayhew CN, Lubert EJ, Skaggs HS, Goodson ML et al. (2005). Mechanism of hsp70i gene bookmarking. Science 307: 421–423.
Yamamoto N, Takemori Y, Sakurai M, Sugiyama K, Sakurai H . (2009). Differential recognition of heat shock elements by members of the heat shock transcription factor family. FEBS J 276: 1962–1974.
Zaarur N, Gabai VL, Porco Jr JA, Calderwood S, Sherman MY . (2006). Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res 66: 1783–1791.
Acknowledgements
This work was supported by Cancéropole Grand Ouest and CNRS. SL and FLM were supported by a fellowship from the French Ministry of Higher Education and Research (MENRT), and FD by a fellowship from the ‘Association pour la Recherche sur le Cancer’ (ARC). We thank Dr V Mezger (UMR CNRS 7216, Paris, France) for the gift of immortalized MEFs, and V Noel for the help in in silico analysis. We also thank Frédéric Percevault for the establishment of a stable clone expressing HSF2 from Hsf2−/− iMEFs.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Lecomte, S., Desmots, F., Le Masson, F. et al. Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability. Oncogene 29, 4216–4224 (2010). https://doi.org/10.1038/onc.2010.171
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.171
Keywords
This article is cited by
-
Decreased ZO1 expression causes loss of time-dependent tight junction function in the liver of ob/ob mice
Molecular Biology Reports (2022)
-
Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction
Cellular Oncology (2019)
-
Roles of heat shock factor 1 beyond the heat shock response
Cellular and Molecular Life Sciences (2018)
-
High-throughput screening system for inhibitors of human Heat Shock Factor 2
Cell Stress and Chaperones (2015)
-
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples
Journal of Ovarian Research (2012)